TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/11/24 16:01 | 6/7/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Young Diane C. | NJ | O | SVP,Chie | S | -1,587 | 35.26 | 0 | -45 | -96 | 2 | D | ||||||||||||||
8/19/22 16:05 | 8/17/22 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Young Diane C. | NJ | O | SVP,Chie | S.d | -709 | 37.30 | 0 | -19 | -29 | 47 | D | ||||||||||||||
11/16/21 16:02 | 11/12/21 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Young Diane C. | NJ | O | SVP,Chie | S.d | -198 | 42.94 | 0 | -5 | -69 | 2 | D | ||||||||||||||
7/17/18 17:49 | 7/16/18 | GTXI | Gtx Inc /de/ | DE | Health | Drug | Pharmaceutical Preparations | Young Diane C. | TN | O | VP,Chief | S.a | -30 | 14.70 | 0 | -2 | -4 | 46 | D | ||||||||||||||
7/17/18 17:03 | 7/16/18 | GTXI | Gtx Inc /de/ | DE | Health | Drug | Pharmaceutical Preparations | Young Diane C. | TN | O | VP,Chief | S | -30 | 14.70 | 0 | -2 | -4 | 46 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |